Gliosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 3%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 43%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05091866	Natural Progesterone for the Treatment of Recurrent Glioblastoma	terminated	Early Phase 1	4	Emory UniversityOTHER	1	May 5, 2026	clinicaltrials
NCT01086345	Radiosurgery Plus Bevacizumab in Glioblastoma	terminated	Early Phase 1	9	Case Comprehensive Cancer CenterOTHER	1	Jul 3, 2018	clinicaltrials
NCT01996527